Skip to main content
Clinical Trials/NCT05616845
NCT05616845
Completed
Not Applicable

A mHealth Application as a Screening Tool for Neonatal Jaundice in Filipino Neonates

Picterus AS1 site in 1 country69 target enrollmentFebruary 2, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Jaundice, Neonatal
Sponsor
Picterus AS
Enrollment
69
Locations
1
Primary Endpoint
validate the reliability of the Picterus mHealth application as a screening tool for neonatal jaundice in Filipino neonates
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

The purpose of the study is to test the reliability of the Picterus smartphone application in Filipino neonates. A descriptive cross-sectional study will be the method to understand the correlation of the modalities and to determine the reliability of the application

Detailed Description

The purpose of the study is to test the reliability of the Picterus smartphone application. The study is designed for Filipino neonates, but implemented in other LMIC. The participants include newborns with or without jaundice, Gestational age \>37 weeks, Age0-14days, Weight \>2500 gram and absence of congenital malformations. Demographic data of the neonates will be collected together with all the performed tests and it will be stored in a secured system. Blood will be drawn and measure the bilirubin level of the neonates in a standard clinical routine and will be compared to the estimated bilirubin performed with the Picterus smartphone application. A descriptive cross-sectional study will be the method to understand the correlation of the modalities and to determine the reliability of the application. It will provide an answer to whether the Picterus smartphone application is reliable to other populations, especially to darker skin and with high melanin content such as Filipino neonates.

Registry
clinicaltrials.gov
Start Date
February 2, 2022
End Date
February 26, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Newborns with or without jaundice
  • Gestational age ≥ 37 weeks
  • Age 0 - 14 days
  • Weight 2500 to 4500 grams
  • Absence of congenital malformations

Exclusion Criteria

  • Newborns with life-threatening conditions or significant illness
  • Newborns diagnosed with inborn errors of metabolism
  • Jaundiced newborns that have undergone phototherapy before screening

Outcomes

Primary Outcomes

validate the reliability of the Picterus mHealth application as a screening tool for neonatal jaundice in Filipino neonates

Time Frame: 5-10 minutes

Validation of smartphone-based screening tool (Picterus JP) for neonatal jaundice in newborns with high melanin content.

Secondary Outcomes

  • correlation between the estimated level of bilirubin detected by the Picterus mHealth application and those obtained using visual Kramer scale in Filipino neonates.(5 minutes)
  • correlation between the estimated levels of bilirubin detected by the Picterus mHealth application and bilirubin serum levels in Filipino neonates(1-2 hours)
  • correlation between the estimated level of bilirubin detected by the Picterus mHealth application and transcutaneous bilirubinometer results in Filipino neonates.(5-10 minutes)
  • sensitivity, specificity, positive and negative predictive value between estimated bilirubin level of the digital images, Kramer examination and TcB.(5 months)

Study Sites (1)

Loading locations...

Similar Trials